Literature DB >> 22569556

Overexpression of protein S100A4 is independently associated with overall survival in stage C colonic cancer but only in cytoplasm at the advancing tumour front.

P S S Kho1, L Jankova, C L-S Fung, C Chan, C Clarke, B P C Lin, G Robertson, M Molloy, P H Chapuis, E L Bokey, O F Dent, S Clarke.   

Abstract

PURPOSE: S100A4, a multifunctional protein, has been linked to the invasive growth and metastases of several human cancers. This study investigated the association between S100A4 and overall survival and other clinicopathological features in patients with stage C colonic cancer.
METHODS: Clinical and pathological data were obtained from a prospective hospital registry of 409 patients who had a resection for stage C colonic cancer. Tissue microarrays for immunohistochemistry were constructed from archived tissue. S100A4 staining intensity and percentage of stained cells were assessed in nuclei and cytoplasm for both the central part of the tumour and at the advancing front. Overall survival was analysed by the Kaplan-Meier method and Cox regression.
RESULTS: Only a high percentage of cells with S100A4 cytoplasmic staining in frontal tissue was associated with poor survival (hazard ratio, 1.6; 95 % CI 1.1-2.2; p = 0.008) after adjustment for other prognostic variables. There was no association between frontal cytoplasmic S100A4 expression and any of 13 other clinicopathological variables.
CONCLUSIONS: High expression of S100A4 in cytoplasm at the advancing front of stage C colonic tumours indicates a poor prognosis. Whether S100A4 can predict response to adjuvant chemotherapy remains to be investigated in a randomised clinical trial.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569556     DOI: 10.1007/s00384-012-1469-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  25 in total

1.  Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer.

Authors:  Caroline L-S Fung; Charles Chan; Lucy Jankova; Owen F Dent; Graham Robertson; Mark Molloy; Les Bokey; Pierre H Chapuis; Betty P C Lin; Stephen J Clarke
Journal:  Histopathology       Date:  2010-02       Impact factor: 5.087

2.  Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).

Authors:  L P Fielding; P A Arsenault; P H Chapuis; O Dent; B Gathright; J D Hardcastle; P Hermanek; J R Jass; R C Newland
Journal:  J Gastroenterol Hepatol       Date:  1991 Jul-Aug       Impact factor: 4.029

Review 3.  S100A4 and metastasis: a small actor playing many roles.

Authors:  Kjetil Boye; Gunhild M Maelandsmo
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

4.  Overexpression of S100A4 is closely associated with progression of colorectal cancer.

Authors:  Yong-Gu Cho; Chang-Jae Kim; Suk-Woo Nam; Shin-Hee Yoon; Sug-Hyung Lee; Nam-Jin Yoo; Jung-Young Lee; Won-Sang Park
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

5.  Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins.

Authors:  Y Bronckart; C Decaestecker; N Nagy; L Harper; B W Schäfer; I Salmon; R Pochet; R Kiss; C W Heizman
Journal:  Histol Histopathol       Date:  2001-07       Impact factor: 2.303

6.  Nuclear S100A4 is a novel prognostic marker in colorectal cancer.

Authors:  Kjetil Boye; Jahn M Nesland; Berit Sandstad; Gunhild M Mælandsmo; Kjersti Flatmark
Journal:  Eur J Cancer       Date:  2010-08-16       Impact factor: 9.162

7.  Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.

Authors:  A K Hemandas; M Salto-Tellez; S H Maricar; A F P K Leong; C K Leow
Journal:  J Surg Oncol       Date:  2006-05-01       Impact factor: 3.454

8.  Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery.

Authors:  Hong-Yi Wang; Jing-Yu Zhang; Jian-Tao Cui; Xiao-Hui Tan; Wen-Mei Li; Jin Gu; You-Yong Lu
Journal:  Oncol Rep       Date:  2010-01       Impact factor: 3.906

9.  The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases.

Authors:  R C Newland; P H Chapuis; M T Pheils; J G MacPherson
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

10.  S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes.

Authors:  S Taylor; S Herrington; W Prime; P S Rudland; R Barraclough
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

View more
  6 in total

1.  Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.

Authors:  Seong Beom Ahn; Charles Chan; Owen F Dent; Abidali Mohamedali; Sun Young Kwun; Candice Clarke; Julie Fletcher; Pierre H Chapuis; Edouard C Nice; Mark S Baker
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

2.  Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.

Authors:  Kjetil Boye; Havjin Jacob; Kari-Anne M Frikstad; Jahn M Nesland; Gunhild M Maelandsmo; Olav Dahl; Arild Nesbakken; Kjersti Flatmark
Journal:  Cancer Med       Date:  2016-06-08       Impact factor: 4.452

3.  Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.

Authors:  Sang-Jeon Lee; Song Yi Choi; Wun-Jae Kim; Meiying Ji; Taek-Gu Lee; Bo-Ra Son; Soon Man Yoon; Rohyun Sung; Eun Jeoung Lee; Sei Jin Youn; Seon Mee Park
Journal:  Diagn Pathol       Date:  2013-06-19       Impact factor: 2.644

Review 4.  Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.

Authors:  Yanqiong Liu; Weizhong Tang; Jian Wang; Li Xie; Taijie Li; Yu He; Xue Qin; Shan Li
Journal:  Diagn Pathol       Date:  2013-11-04       Impact factor: 2.644

5.  Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer.

Authors:  Seong Beom Ahn; Abidali Mohamedali; Charles Chan; Julie Fletcher; Sun Young Kwun; Candice Clarke; Owen F Dent; Pierre H Chapuis; Edouard Nice; Mark S Baker
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

Review 6.  S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction.

Authors:  Mathias Dahlmann; Dennis Kobelt; Wolfgang Walther; Giridhar Mudduluru; Ulrike Stein
Journal:  Cancers (Basel)       Date:  2016-06-20       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.